Search Tag: STRM.BIO
2023 24 Jul
STRM.BIO, a pre-clinical, VC-backed biotechnology company that is leveraging extracellular vesicles (EVs) to deliver gene therapies and developing new therapeutics for rare blood diseases announced the appointment of Minnie Mildwoff, to its Board of Directors. Ms. Mildwoff has been a member of the company's Scientific Advisory Board (SAB) since May...Read more
2022 13 Jun
STRM.BIO, a pre-clinical, VC-backed biotechnology company that is leveraging extracellular vesicles (EVs) to deliver gene therapies, and developing new therapeutics for rare blood diseases, announced the appointment of Vanessa Salazar as Vice President of Business Development. Mrs. Salazar is a skilled corporate development executive with more than...Read more